Contract 75N95022C00020
Vesicle Therapeutics Inc · Department Of Health And Human Services · September 20, 2022
Vesicle Therapeutics Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 20, 2022 for $475,000 of work in research and development in biotechnology (except nanobiotechnology). Performance is in Longmont, CO. It was awarded under a small business set-aside. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on July 2, 2024.
Contract details
- PIID
- 75N95022C00020
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Longmont, CO
- First action
- September 20, 2022
- Latest action
- July 2, 2024
Description
NEUROTROPIC GECTOSOMES AS A CNS GENE DELIVERY SYSTEM FOR AD/ADRD THERAPY DEVELOPMENT
Modification timeline
-
July 2, 2024Mod P00003$0
-
September 5, 2023Mod P00002$0
-
March 14, 2023Mod P00001$0
-
September 20, 2022Base award$475.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | The Boeing Company | 1 | $4.44B |
| 2 | Advanced Technology International | 9 | $3.35B |
| 3 | Amgen USA Inc | 2 | $774.69M |
| 4 | Siga Technologies, Inc. | 1 | $624.44M |
| 5 | Icon Government And Public Health Solutions, Inc. | 16 | $404.80M |
| 6 | Technical Resources International, Inc. | 19 | $395.29M |
| 7 | Allucent Government Services (Us) Llc | 9 | $384.26M |
| 8 | Mapp Biopharmaceutical, Inc. | 7 | $354.24M |
| 9 | Ppd Development Lp | 18 | $331.02M |
| 10 | Albert B. Sabin Vaccine Institute, Inc. (The) | 2 | $305.87M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95022C00020?
Contract 75N95022C00020 is a federal contract awarded to Vesicle Therapeutics Inc by Department Of Health And Human Services on September 20, 2022 for $475,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 3 times since the base award.
Who won contract 75N95022C00020?
Vesicle Therapeutics Inc won contract 75N95022C00020 from Department Of Health And Human Services.
How much is contract 75N95022C00020 worth?
Contract 75N95022C00020 has obligated $475,000 to date.